Kietrys David M, Barr Ann E, Barbe Mary F
Department of Rehabilitation and Movement Sciences, University of Medicine and Dentistry of New Jersey, School of Health Related Professions, Stratford, New Jersey, USA.
J Mot Behav. 2011;43(6):465-76. doi: 10.1080/00222895.2011.627897. Epub 2011 Nov 16.
The authors elucidate exposure-response relationships between repetitive tasks, inflammation, and motor changes with work-related musculoskeletal disorders. Using a rat model of reaching and handle pulling, they examined effects of performing a high-repetition, low-force (HRLF); low-repetition, high-force (LRHF); or high-repetition, high-force (HRHF) task (2 hr/day, 3 days/week, 12 weeks) on reach rate and force, percentage of successful reaches, duration of participation, and grip strength. Reach rate and reach force improved with HRLF, and percentage success increased in all groups in Week 9, and in HRLF and HRHF in Week 12, indicative of skill acquisition. Duration and grip strength showed force-dependent declines with task performance. A subset of HRHF rats received ibuprofen in Weeks 5-12. Ibuprofen significantly improved reach rate, reach force, and duration in treated rats, indicative of an inflammatory influence on reach performance. Ibuprofen improved percentage of successful reaches in Week 9, although this increase was not sustained. However, declines in grip strength, a nocifensive behavior, were not prevented by ibuprofen. Examination of cervical spinal cords of untreated and ibuprofen treated HRHF rats showed increased IL-1beta, an inflammatory cytokine, in neurons. These findings suggest that only a preventive intervention could have addressed all motor declines.
作者阐明了重复性任务、炎症与运动变化之间与工作相关的肌肉骨骼疾病的暴露-反应关系。他们使用大鼠抓握和拉柄模型,研究了执行高重复、低强度(HRLF);低重复、高强度(LRHF);或高重复、高强度(HRHF)任务(每天2小时,每周3天,共12周)对抓握速度和力量、成功抓握的百分比、参与持续时间和握力的影响。HRLF组的抓握速度和抓握力有所提高,所有组在第9周成功抓握的百分比均增加,HRLF组和HRHF组在第12周增加,表明技能获得。持续时间和握力随任务执行呈力依赖性下降。HRHF组的一部分大鼠在第5至12周接受布洛芬治疗。布洛芬显著改善了治疗大鼠的抓握速度、抓握力和持续时间,表明炎症对抓握性能有影响。布洛芬在第9周提高了成功抓握的百分比,尽管这种增加没有持续。然而,握力下降这一伤害性防御行为并未被布洛芬阻止。对未治疗和布洛芬治疗的HRHF大鼠的颈脊髓检查显示,神经元中炎症细胞因子IL-1β增加。这些发现表明,只有预防性干预才能解决所有运动能力下降的问题。